Back to Agenda
Session 4: Concrete Actions among Individual Partners and Stakeholders to Prepare for the HTAR Implementation
Session Chair(s)
Dirk Van Den Steen
HTA Deputy Head of Unit, European Commission, Belgium
Niklas Hedberg, MPharm
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
The different stakeholders will share what they have been doing and what they are currently doing to prepare themselves to be ready by the time of the HTAR application (education, mobilizing resources, adapting processes and organisation). They will discuss how they can work together, while processes are simultaneously evolving as the key parts of the Pharmaceutical Strategy are being delivered.
Speaker(s)
National HTA Agencies’ Perspective
Niklas Hedberg, MPharm
HTACG Co-Chair & Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV, Sweden
National HTA Agencies’ Perspective
Anne Willemsen, MSc
Senior Project Manager, Joint Production Co-Lead Partner - Pharmaceuticals, ZIN - National Health Care Institute, Netherlands
EMA Perspective
Michael Berntgen, PhD
Head of Scientific Evidence Generation, European Medicines Agency, Netherlands
Industry Perspective
Alexander Natz, JD
Secretary General, European Confederation of Pharmaceutical Entrepreneurs, Belgium
Industry Perspective
Adam Parnaby
Senior Director, Market Access Policy, Bristol Myers Squibb, Belgium
Patient Perspective
Antonella Cardone
Director, Cancer Patients Europe, Belgium
Payer Perspective
Rasmus Syberg Hazelton, MSc
Senior Advisor International Affairs, Amgros, Denmark
Have an account?